Berget Cari, Sherr Jennifer L, DeSalvo Daniel J, Kingman Ryan S, Stone Sheri L, Brown Sue A, Nguyen Alex, Barrett Leslie, Ly Trang T, Forlenza Gregory P
Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO.
Section of Pediatric Endocrinology, Yale School of Medicine, New Haven, CT.
Clin Diabetes. 2022 Spring;40(2):168-184. doi: 10.2337/cd21-0083. Epub 2022 Apr 15.
Automated insulin delivery (AID) systems, which connect an insulin pump, continuous glucose monitoring system, and software algorithm to automate insulin delivery based on real-time glycemic data, hold promise for improving outcomes and reducing therapeutic burden for people with diabetes. This article reviews the features of the Omnipod 5 Automated Insulin Delivery System and how it compares to other AID systems available on or currently under review for the U.S. market. It also provides practical guidance for clinicians on how to effectively train and onboard people with diabetes on the Omnipod 5 System, including how to personalize therapy and optimize glycemia. Many people with diabetes receive their diabetes care in primary care settings rather than in a diabetes specialty clinic. Therefore, it is important that primary care providers have access to resources to support the adoption of AID technologies such as the Omnipod 5 System.
自动胰岛素输送(AID)系统将胰岛素泵、连续血糖监测系统和软件算法连接起来,根据实时血糖数据自动输送胰岛素,有望改善糖尿病患者的治疗效果并减轻治疗负担。本文回顾了Omnipod 5自动胰岛素输送系统的特点,以及它与美国市场上现有或正在审评的其他AID系统相比有何异同。它还为临床医生提供了实用指导,介绍如何有效地对糖尿病患者进行Omnipod 5系统的培训和指导,包括如何个性化治疗和优化血糖水平。许多糖尿病患者在初级保健机构接受糖尿病护理,而非在糖尿病专科诊所。因此,初级保健提供者能够获取资源以支持采用诸如Omnipod 5系统等AID技术非常重要。